- Home
- BCAL vs ORIC Comparison
BCAL vs ORIC Comparison
Compare BCAL & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAL
- ORIC
- Stock Information
- Founded
- BCAL 2001
- ORIC 2014
- Country
- BCAL United States
- ORIC United States
- Employees
- BCAL 204
- ORIC N/A
- Industry
- BCAL Major Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- BCAL Finance
- ORIC Health Care
- Exchange
- BCAL Nasdaq
- ORIC Nasdaq
- Market Cap
- BCAL 464.0M
- ORIC 545.5M
- IPO Year
- BCAL N/A
- ORIC 2020
- Fundamental
- Price
- BCAL $14.38
- ORIC $6.14
- Analyst Decision
- BCAL Strong Buy
- ORIC Strong Buy
- Analyst Count
- BCAL 1
- ORIC 9
- Target Price
- BCAL $20.00
- ORIC $18.43
- AVG Volume (30 Days)
- BCAL 120.2K
- ORIC 674.4K
- Earning Date
- BCAL 05-07-2025
- ORIC 05-05-2025
- Dividend Yield
- BCAL N/A
- ORIC N/A
- EPS Growth
- BCAL N/A
- ORIC N/A
- EPS
- BCAL 0.22
- ORIC N/A
- Revenue
- BCAL $106,054,000.00
- ORIC N/A
- Revenue This Year
- BCAL $77.98
- ORIC N/A
- Revenue Next Year
- BCAL $5.12
- ORIC N/A
- P/E Ratio
- BCAL $67.09
- ORIC N/A
- Revenue Growth
- BCAL 9.78
- ORIC N/A
- 52 Week Low
- BCAL $12.30
- ORIC $5.78
- 52 Week High
- BCAL $18.49
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- BCAL 28.55
- ORIC 34.15
- Support Level
- BCAL $14.70
- ORIC $5.78
- Resistance Level
- BCAL $16.24
- ORIC $8.11
- Average True Range (ATR)
- BCAL 0.69
- ORIC 0.54
- MACD
- BCAL -0.03
- ORIC -0.11
- Stochastic Oscillator
- BCAL 1.94
- ORIC 15.45
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through strong partnerships with its clients.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.